These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30745230)

  • 1. Disparities in the Use of Intravenous t-PA among Ischemic Stroke Patients: Population-based Recent Temporal Trends.
    Faysel MA; Singer J; Cummings C; Stefanov DG; Levine SR
    J Stroke Cerebrovasc Dis; 2019 May; 28(5):1243-1251. PubMed ID: 30745230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex and racial disparity in utilization and outcomes of t-PA and thrombectomy in acute ischemic stroke.
    Nagaraja N; Olasoji EB; Patel UK
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104954. PubMed ID: 32807414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers.
    Aparicio HJ; Carr BG; Kasner SE; Kallan MJ; Albright KC; Kleindorfer DO; Mullen MT
    J Am Heart Assoc; 2015 Oct; 4(10):e001877. PubMed ID: 26467999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in the Utilization of Thrombectomy for Acute Stroke.
    Rinaldo L; Rabinstein AA; Cloft H; Knudsen JM; Castilla LR; Brinjikji W
    Stroke; 2019 Sep; 50(9):2428-2432. PubMed ID: 31366313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities and Trends in Door-to-Needle Time: The FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).
    Oluwole SA; Wang K; Dong C; Ciliberti-Vargas MA; Gutierrez CM; Yi L; Romano JG; Perez E; Tyson BA; Ayodele M; Asdaghi N; Gardener H; Rose DZ; Garcia EJ; Zevallos JC; Foster D; Robichaux M; Waddy SP; Sacco RL; Rundek T;
    Stroke; 2017 Aug; 48(8):2192-2197. PubMed ID: 28706119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends in the Use of Acute Recanalization Therapies for Ischemic Stroke in Patients with Cancer.
    Chatterjee A; Merkler AE; Murthy SB; Burch JE; Chen ML; Gialdini G; Kamel H; Ballman KV; Navi BB
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2255-2261. PubMed ID: 31153762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke.
    Kunisawa S; Kobayashi D; Lee J; Otsubo T; Ikai H; Yokota C; Minematsu K; Imanaka Y
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):724-31. PubMed ID: 23910512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis.
    Gadalean F; Simu M; Parv F; Vorovenci R; Tudor R; Schiller A; Timar R; Petrica L; Velciov S; Gluhovschi C; Bob F; Mihaescu A; Timar B; Spasovski G; Ivan V
    PLoS One; 2017; 12(10):e0185589. PubMed ID: 29040276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S; Dharmasaroja P; Kummark U
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
    Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
    Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association between t-PA Administration and In-Hospital Mortality following Acute Ischemic Stroke in Puerto Rican Patients.
    Shah K; Kohrman S; Alkhatib S; González J; Santiago F; Varella M; Zevallos J
    P R Health Sci J; 2016 Dec; 35(4):215-219. PubMed ID: 27898168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex Disparities in Ischemic Stroke Care: FL-PR CReSD Study (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities).
    Asdaghi N; Romano JG; Wang K; Ciliberti-Vargas MA; Koch S; Gardener H; Dong C; Rose DZ; Waddy SP; Robichaux M; Garcia EJ; Gonzalez-Sanchez JA; Burgin WS; Sacco RL; Rundek T
    Stroke; 2016 Oct; 47(10):2618-26. PubMed ID: 27553032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and outcomes in stroke mimics after intravenous tissue plasminogen activator administration: a single-center experience.
    Lewandowski C; Mays-Wilson K; Miller J; Penstone P; Miller DJ; Bakoulas K; Mitsias P
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):48-52. PubMed ID: 25440358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.